1.3.6.1.4.1.19376.1.5.3.1.4.7.2
Development Only
The PCC Wiki Content is used only for development of IHE PCC Content. The Normative content of the PCC Technical Framework and the current supplements can be found at http://www.ihe.net/Technical_Framework/index.cfm#PCC
Product Entry 1.3.6.1.4.1.19376.1.5.3.1.4.7.2
The product entry describes a medication or immunization used in a <substanceAdministration> or <supply> act. It adopts the constraints of the ASTM/HL7 Continuity of Care Document.
Uses
See Templates using Product Entry
Specification
<manufacturedProduct>
<templateId root='1.3.6.1.4.1.19376.1.5.3.1.4.7.2'/>
<templateId root='2.16.840.1.113883.10.20.1.53'/>
<manufacturedMaterial>
<code code='' displayName='' codeSystem='' codeSystemName=''>
<originalText><reference value=''/></originalText>
</code>
<name></name>
</manufacturedMaterial>
</manufacturedProduct>
|
<manufacturedProduct>
<templateId root='1.3.6.1.4.1.19376.1.5.3.1.4.7.2'/>
<templateId root='2.16.840.1.113883.10.20.1.53'/>
<manufacturedMaterial>
The name and strength of the medication are specified in the elements under the <manufacturedMaterial> element.
<code code=' ' displayName=' ' codeSystem=' ' codeSystemName=' '>
<originalText><reference value=' '/></originalText>
The <code> element of the <manufacturedMaterial> shall contain a <reference> whose URI value points to the generic name and strength of the medication, or just the generic name alone if strength is not relevant. This may be coded using a controlled vocabulary, such as RxNorm, First Databank, or other vocabulary system for medications, and should be the code that represents the generic medication name and strength (e.g., acetaminophen and oxycodone -5/325), or just the generic medication name alone if strength is not relevant (Acetaminophen). .
| Note: | Since the text is supplied from the narrative, the implication is that if you supply the components of a combination medication in an entry, you must also display these in the narrative text, otherwise you would not be able to break the combination medication down into its component parts. This is entirely consistent with the CDA Release 2.0 requirements that the narrative supply the necessary and relevant human readable information content. |
The <code> element is also used to support coding of the medication. If coded, it must provide a code and codeSystem using a controlled vocabulary for medications. The displayName for the code and codeSystemName should be provided as well for diagnostic and human readability purposes, but are not required. The table below provides the codeSystem and codeSystemName for several controlled terminologies that may be used to encode medications.
| codeSystem | codeSystemName | Description |
|---|---|---|
| 2.16.840.1.113883.6.88 | RxNorm | RxNorm |
| 2.16.840.1.113883.6.69 | NDC | National Drug Codes |
| 2.16.840.1.113883.6.63 | FDDC | First DataBank Drug Codes |
| 2.16.840.1.113883.6.96 | SNOMED-CT | SNOMED Controlled Terminology |
<name>
The <name> element should contain the brand name of the medication (or active ingredient in the case of subordinate <substanceAdministration> elements used to record components of a medication).